Phathom Pharmaceuticals(PHAT) - 2023 Q4 - Earnings Call Presentation
Closing Remarks Terrie Curran, President & Chief Executive Officer Question & Answer FOURTH QUARTER & FULL YEAR 2023 EARNINGS CONFERENCE CALL MARCH 2024 NASDAQ: PHAT Today's Agenda Business Update Terrie Curran, President & Chief Executive Officer US Commercial Launch Progress Martin Gilligan, Chief Commercial Officer Fourth Quarter & Full Year 2023 Results Molly Henderson, Chief Financial & Business Officer Terrie Curran, President & Chief Executive Officer Martin Gilligan, Chief Commercial Officer Molly H ...